Nuvalent, Inc. (NUVL)
107.46
+2.51
(+2.39%)
USD |
NASDAQ |
May 27, 16:00
107.46
0.00 (0.00%)
After-Hours: 16:33
Nuvalent Free Cash Flow : -312.79M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cogent Biosciences, Inc. | -286.27M |
| BioMarin Pharmaceutical, Inc. | 759.12M |
| Olema Pharmaceuticals, Inc. | -148.72M |
| Vera Therapeutics, Inc. | -293.81M |
| Tyra Biosciences, Inc. | -102.47M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -92.40M |
| Cash from Investing (Quarterly) | -19.41M |
| Cash from Financing (Quarterly) | 9.801M |
| Free Cash Flow Per Share (Quarterly) | -1.174 |
| Free Cash Flow to Equity (Quarterly) | -92.40M |
| Free Cash Flow to Firm (Quarterly) | -92.40M |
| Free Cash Flow Yield | -3.91% |